Michael Baria: Platelet Concentration and PRP Outcomes in Partial Rotator Cuff Tears
Michael Baria, Lead for The Early Osteoarthritis and Joint Health Program at The Ohio State University Wexner Medical Center, Head Team Physician for Ohio State Wrestling at The Ohio State University Department of Athletics, shared a post on LinkedIn about a recent article by Joseph J Lim et al. published in Orthopaedic Journal of Sports Medicine, adding:
”In this meta-analysis of level 1, randomized studies, platelet concentration did not influence outcomes for partial rotator cuff tears.
Basic science has repeatedly shown that worse histopathology is best treated with higher platelets and higher leukocytes.
However, this review shows that we haven’t translated that to clinical care (yet).
High vs low dose (as defined by the authors) didn’t make a difference.
Also, PRP vs no PRP didn’t make a difference.
How do you handle these?
What do you make of these findings?
In our experience, it’s very difficult to design controlled rotator cuff studies for a myriad of reasons.
Tendinopathy isn’t a partial tear.
There are confounding pathologies like AC, biceps, etc.
Finally, our clinical experience has consistently demonstrated that moderate dose (general range of 6-10 B) PRP delivered to the subacromial bursa with proper rehab works well and avoids complications (I.e. frozen shoulder) from intra-tendinous injections.”
Title: Platelet Concentration Is Not Associated With Improved Pain for Partial-Thickness Rotator Cuff Tears Treated With Platelet-Rich Plasma: A Systematic Review and Meta-analysis With Meta-regression of Level 1 Randomized Controlled Trials
Authors: Joseph J Lim, John W Belk, Carson Keeter, Emilea A Stepaniuk, Sophie D Gerber, Jacob F Oeding, Eric C McCarty, Rachel M Frank
See more in the gallery.
Stay updated on all scientific advances with Hemostasis Today.
-
Sep 25, 2026, 09:49Haley Coleman: Volunteering to Support Hemophilia Awareness
-
Sep 25, 2026, 08:55Hitarth Mehta: BHMS Students Gain Practical Exposure to Haemophilia Diagnosis
-
Sep 25, 2026, 07:25Varun Capoor: How Therapeutic Apheresis and Transfusion Medicine Can Complement Clinical Management in SCD
-
Sep 25, 2026, 07:14Manshi Kesharwani: SAK-GQDs Modulate Thrombus Burden and Endothelial Function in Deep Vein Thrombosis
-
Sep 25, 2026, 06:20Farjah Hassan Algahtani: How Can We Better Identify Patients at Risk of Blood Clots after Metabolic and Bariatric Surgery?
-
Sep 25, 2026, 05:59Carla Lewis: Kids Conquering Sickle Disease Joins Nemours Children’s Hospital for 2nd Annual Awareness Event
-
Sep 25, 2026, 05:47Omid Seidizadeh: Evolutionary Constraint and Population Variation Across Coagulation Genes
-
Sep 25, 2026, 05:40Gerald Bertrand: Presenting UMi-NGS Non-Invasive Foetal HPA Genotyping at DGTI 2026
-
Sep 25, 2026, 05:33Urge Congress to support the Sickle Cell Disease Comprehensive Care Act – ASH